Colorectal cancer lines (n = 30) showed no difference or slightly reduced UPP1 in mutant KRAS lines (Extended Data Fig. 8a), consistent with the data in Extended Data Fig. 6d. This evidence concerns the gene KRAS and colorectal cancer.